Zanubrutinib and Rituximab for the Treatment of Previously Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Clinical trial NCT04458610 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04458610
- Sponsor
- M.D. Anderson Cancer Center
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-05-26
- Primary completion
- 2027-05-26
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.